bufalin and Peritoneal Neoplasms

bufalin has been researched along with Peritoneal Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Deng, M; Liu, J; Ma, Y; Qu, X; Song, J; Tang, Y; Wang, S; Wen, Z; Yang, C; Zhang, Y; Zou, D1

Other Studies

1 other study(ies) available for bufalin and Peritoneal Neoplasms

ArticleYear
Bufalin inhibits peritoneal dissemination of gastric cancer through endothelial nitric oxide synthase-mitogen-activated protein kinases signaling pathway.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2021, Volume: 35, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Bufanolides; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinases; Nitric Oxide Synthase Type III; Peritoneal Neoplasms; Signal Transduction; Stomach Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2021